乳腺癌中雌激素受体的定量表达:临床与分子意义
该研究在大规模乳腺癌队列(n=7559)中按百分比和染色强度对雌激素受体(ER)表达分类,分析其与临床病理参数及内分泌治疗(ET)反应的关系,并用癌症基因组图谱乳腺癌队列(n=1047)进行转录组分析。结果显示ET反应与ER表达呈比例相关,在10%、50%和100%处观察到显著差异,组织化学评分(H-score)提供额外预后和预测信息。
要点
- ER表达1-9%的肿瘤特征与ER阴性(<1%)肿瘤相似。
- ET最大反应见于ER表达100%的肿瘤,与ER<100%肿瘤反应显著不同。
- H-score在ER百分比基础上增加显著预后价值,在30、100和200处观察到显著结局差异。
核心结论
- ET反应与ER表达呈统计学比例相关,在10%、50%和100%处观察到显著差异;H-score增加预后和预测信息。
研究设计与样本
- 在大型乳腺癌队列(n=7559)中按百分比和染色强度分类ER表达,与临床病理参数及患者ET反应进行相关性分析。
- 癌症基因组图谱数据乳腺癌队列(n=1047)按ER表达分层,完成转录组分析以理解ER异质性的分子基础。
主要发现
- ER表达的定量比例增加与有利预后参数呈正相关。
- ER表达1-9%的肿瘤特征上与ER阴性(<1%)肿瘤相似。
- ET最大反应见于ER表达100%的肿瘤,与ER<100%的肿瘤反应显著不同;ER表达50%和10%的肿瘤观察到生存率显著降低。
- H-score同时考虑染色强度和百分比,在ER百分比基础上增加显著预后价值,在H-score为30、100和200处观察到显著结局差异。
- ER表达与ESR1 mRNA表达及ER调控基因表达呈正相关;通路分析识别出不同ER阳性组中关键癌症相关通路的差异表达。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oestrogen receptor (ER) positive breast cancer (BC) patients are eligible for endocrine therapy (ET), regardless of ER immunohistochemical expression level. There is a wide spectrum of ER expression and the response to ET is not uniform. This study aimed to assess the clinical and molecular consequences of ER heterogeneity with respect to ET-response. METHODS: ER expression, categorised by percentage and staining intensity in a large BC cohort (n = 7559) was correlated with clinicopathological parameters and patient ET response. The Cancer Genome Atlas Data BC cohort (n = 1047) was stratified by ER expression and transcriptomic analysis completed to better understand the molecular basis of ER heterogeneity. RESULTS: The quantitative proportional increase in ER expression was positively associated with favourable prognostic parameters. Tumours with 1-9% ER expression were characteristically similar to ER-negative (<1%) tumours. Maximum ET-response was observed in tumours with 100% ER expression, with responses significantly different to tumours exhibiting ER at < 100% and significantly decreased survival rates were observed in tumours with 50% and 10% of ER expression. The Histochemical-score (H-score), which considers both staining intensity and percentage, added significant prognostic value over ER percentage alone with significant outcome differences observed at H-scores of 30, 100 and 200. There was a positive correlation between ER expression and ESR1 mRNA expression and expression of ER-regulated genes. Pathway analysis identified differential expression in key cancer-related pathways in different ER-positive groups. CONCLUSION: ET-response is statistically proportionally related to ER expression with significant differences observed at 10%, 50% and 100%. The H-score adds prognostic and predictive information.
引用
- Makhlouf S, Quinn C, Toss M, et al. Quantitative expression of oestrogen receptor in breast cancer: Clinical and molecular significance. Eur J Cancer. 2023. PMID: 38103327. doi:10.1016/j.ejca.2023.113473
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。